Research Grant in Allergic Rhinitis and Urticaria

The Canadian Asthma, Allergy and Immunology Foundation (CAAIF) is a charitable organization, established to increase educational opportunities and research resources for the Canadian Allergy and Immunology community. This grant is focused on the study of allergic rhinitis or urticaria and will provide one grant of $50,000. The CAAIF Research Committee will oversee the application review process. The goal of the Foundation is not to replace larger granting bodies who fund allergy and/or immunology research. Due to the limited nature of our funds, the competition may be a means of securing seed or supplemental funding for larger projects or to initiate an innovative project idea that requires preliminary data before a larger grant application can be made. Projects that are more appropriately aimed at the pharmaceutical industry directly will not be considered. About Aralez Aralez Pharmaceuticals Canada Inc. is a leading Canadian specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products primarily in allergy, dermatology and other specialty areas.

Agency Name: 
Canadian Asthma, Allergy and Immunology Foundation
Contact Name: 
Penny D'Agnone
Grant Amount: 
This grant is focused on the study of allergic rhinitis or urticaria and will provide one grant of $50,000.
Grant Location: 
External
External Deadline: 
Thursday, February 28, 2019
Grant Type: 
Research
Grant Area: 
Health
Grant Eligibility: 
Faculty